Literature DB >> 170953

Marek's disease--the disease and its prevention by vaccination.

P M Biggs.   

Abstract

Marek's disease (MD) is a common lymphoproliferative disease of the domestic chicken caused by a cell associated herpesvirus. Vaccines used for the prophylaxis of MD have been derived from non-pathogenic field Marek's disease virus (MDV), pathogenic MDV and the herpesvirus of turkeys (HVT). Vaccines derived from MDV have been developed by attenuation of virus strains which produce the acute form of MD and virus strains which produce the classical form. They have also been developed by suitable modification, where necessary, of non-pathogenic MDV. All MDV derived vaccines have to be used in the cell associated form. The turkey herpesvirus vaccine can be used in either the cell associated or cell free lyophilized form. All these types of vaccine appear to be safe and to provide significant levels of protection under field conditions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170953      PMCID: PMC2149595     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  18 in total

1.  [Vaccination tests against Marek's disease by application of an attenuated Marek-Herpes-virus and a Herpes-virus of turkey].

Authors:  E Vielitz; H Landgraf
Journal:  Dtsch Tierarztl Wochenschr       Date:  1971-12-01

2.  Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys.

Authors:  B W Calnek; S B Hitchner; H K Adldinger
Journal:  Appl Microbiol       Date:  1970-11

3.  Field trials with the herpes virus of turkeys (HVT) strain FC126 as a vaccine against Marek's disease.

Authors:  H G Purchase; W Okazaki; B R Burmester
Journal:  Poult Sci       Date:  1971-05       Impact factor: 3.352

4.  Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek's disease herpesvirus.

Authors:  H G Purchase; W Okazaki
Journal:  Avian Dis       Date:  1971 Apr-Jun       Impact factor: 1.577

5.  The effect of early natural exposure to Marek's disease on immunization of breeders by vaccination.

Authors:  R F Ball; J F Hill; J Lyman; A Wyatt
Journal:  Poult Sci       Date:  1971-03       Impact factor: 3.352

6.  Field trials with an attenuated cell associated vaccine for Marek's disease.

Authors:  P M Biggs; L N Payne; B S Milne; A E Churchill; R C Chubb; D G Powell; A H Harris
Journal:  Vet Rec       Date:  1970-12-05       Impact factor: 2.695

7.  Field trials of vaccines for Marek's disease.

Authors:  C S Eidson; D P Anderson; S H Kleven; J Brown
Journal:  Avian Dis       Date:  1971 Apr-Jun       Impact factor: 1.577

8.  Hematopoietic destruction in Marek's disease.

Authors:  R M Jakowski; T N Fredrickson; T W Chomiak; R E Luginbuhl
Journal:  Avian Dis       Date:  1970-05       Impact factor: 1.577

9.  Effect of maternal antibody on Marek's disease.

Authors:  R C Chubb; A E Churchill
Journal:  Vet Rec       Date:  1969-09-13       Impact factor: 2.695

10.  The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture.

Authors:  A E Churchill; R C Chubb; W Baxendale
Journal:  J Gen Virol       Date:  1969-06       Impact factor: 3.891

View more
  2 in total

1.  No homology detectable between Marek's disease virus (MDV) DNA and herpesvirus of the turkey (HVT) DNA.

Authors:  C Kaschka-Dierich; G W Bornkamm; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

2.  Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency.

Authors:  Xiaoping Cui; Lucy F Lee; Willie M Reed; Hsing-Jien Kung; Sanjay M Reddy
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.